Please assess the completion status of the following clinical trial:

Trial Title: Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Schizophrenia~* 18-65 years~* No hospitalization for an exacerbation of schizophrenia within two months prior to screening and during the screening period~Exclusion Criteria:~* Subjects who are acutely psychotic or subjects with current Axis I primary psychiatric diagnosis other than schizophrenia~* At significant risk of suicide, and the potential for violent behavior (likely to harm themselves or others) based on history

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).